JPS57126420A - Drug for digestive organ - Google Patents

Drug for digestive organ

Info

Publication number: JPS57126420A
Authority: JP; Japan
Prior art keywords: carnitine; drug; acyl; effective; active constituent
Prior art date: 1981-01-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP1065481A

Other languages

English (en)

Japanese (ja)

Other versions

JPH0340010B2 (mo

Inventor

Eiji Murakami

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-01-26

Filing date

1981-01-26

Publication date

1982-08-06

1981-01-26 Application filed by Individual filed Critical Individual

1981-01-26 Priority to JP1065481A priority Critical patent/JPS57126420A/ja

1982-08-06 Publication of JPS57126420A publication Critical patent/JPS57126420A/ja

1990-12-21 Priority to JP41814490A priority patent/JPH03246221A/ja

1991-06-17 Publication of JPH0340010B2 publication Critical patent/JPH0340010B2/ja

Status Granted legal-status Critical Current

Links

229940079593 drug Drugs 0.000 title abstract 5
239000003814 drug Substances 0.000 title abstract 5
210000004798 organs belonging to the digestive system Anatomy 0.000 title abstract 3
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 3
229960004203 carnitine Drugs 0.000 abstract 3
239000000470 constituent Substances 0.000 abstract 2
229960001518 levocarnitine Drugs 0.000 abstract 2
PHIQHXFUZVPYII-LURJTMIESA-N (S)-carnitine Chemical compound C[N+](C)(C)C[C@@H](O)CC([O-])=O PHIQHXFUZVPYII-LURJTMIESA-N 0.000 abstract 1
208000022531 anorexia Diseases 0.000 abstract 1
230000036528 appetite Effects 0.000 abstract 1
235000019789 appetite Nutrition 0.000 abstract 1
230000037396 body weight Effects 0.000 abstract 1
206010061428 decreased appetite Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
231100000053 low toxicity Toxicity 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
210000003205 muscle Anatomy 0.000 abstract 1
231100000957 no side effect Toxicity 0.000 abstract 1
210000001819 pancreatic juice Anatomy 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Landscapes

Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

JP1065481A 1981-01-26 1981-01-26 Drug for digestive organ Granted JPS57126420A (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
JP1065481A JPS57126420A (en)	1981-01-26	1981-01-26	Drug for digestive organ
JP41814490A JPH03246221A (ja)	1981-01-26	1990-12-21	発育促進剤

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP1065481A JPS57126420A (en)	1981-01-26	1981-01-26	Drug for digestive organ

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP41814490A Division JPH03246221A (ja)	1981-01-26	1990-12-21	発育促進剤

Publications (2)

Publication Number	Publication Date
JPS57126420A true JPS57126420A (en)	1982-08-06
JPH0340010B2 JPH0340010B2 (mo)	1991-06-17

Family

ID=11756204

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP1065481A Granted JPS57126420A (en)	1981-01-26	1981-01-26	Drug for digestive organ

Country Status (1)

Country	Link
JP (1)	JPS57126420A (mo)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839159A (en) *	1988-02-08	1989-06-13	Topicarn, Inc.	Topical L-carnitine composition
US4883672A (en) *	1988-04-29	1989-11-28	Shug Austin L	Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
GB2230953A (en) *	1989-05-05	1990-11-07	Sigma Tau Ind Farmaceuti	Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease
WO1991005554A1 (en) *	1989-10-23	1991-05-02	University Of Georgia Research Foundation, Inc.	Carnitine supplemented cat fish diet
US5071874A (en) *	1989-06-14	1991-12-10	Lonza Ltd.	L-carnitine magnesium citrate
US5073376A (en) *	1989-12-22	1991-12-17	Lonza Ltd.	Preparations containing l-carnitine
US5240961A (en) *	1992-07-02	1993-08-31	Shug Austin L	Method of treating reduced insulin-like growth factor and bone loss associated with aging
US5314689A (en) *	1988-05-26	1994-05-24	Attilio Bernardini	Acyl-carnitine for the treatment and prevention of viral infections
US5362753A (en) *	1993-04-19	1994-11-08	Lonza Ltd.	Method of increasing the hatchability of eggs by feeding hens carnitine
US6242487B1 (en)	1996-12-03	2001-06-05	Lonza, Inc.	Carnitine supplemented diets for gestating and lactating swine

1981
- 1981-01-26 JP JP1065481A patent/JPS57126420A/ja active Granted

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEM.ABSTR *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839159A (en) *	1988-02-08	1989-06-13	Topicarn, Inc.	Topical L-carnitine composition
US4883672A (en) *	1988-04-29	1989-11-28	Shug Austin L	Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
US5314689A (en) *	1988-05-26	1994-05-24	Attilio Bernardini	Acyl-carnitine for the treatment and prevention of viral infections
GB2230953A (en) *	1989-05-05	1990-11-07	Sigma Tau Ind Farmaceuti	Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease
GB2230953B (en) *	1989-05-05	1993-03-24	Sigma Tau Ind Farmaceuti	Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease
US5071874A (en) *	1989-06-14	1991-12-10	Lonza Ltd.	L-carnitine magnesium citrate
WO1991005554A1 (en) *	1989-10-23	1991-05-02	University Of Georgia Research Foundation, Inc.	Carnitine supplemented cat fish diet
US5030657A (en) *	1989-10-23	1991-07-09	University Of Georgia Research Foundation, Inc.	L-carnitine supplemented catfish diet
US5073376A (en) *	1989-12-22	1991-12-17	Lonza Ltd.	Preparations containing l-carnitine
WO1994001101A1 (en) *	1992-07-02	1994-01-20	Shug Austin L	A method of treating reduced insulin-like growth factor and bone loss associated with aging
US5240961A (en) *	1992-07-02	1993-08-31	Shug Austin L	Method of treating reduced insulin-like growth factor and bone loss associated with aging
US5362753A (en) *	1993-04-19	1994-11-08	Lonza Ltd.	Method of increasing the hatchability of eggs by feeding hens carnitine
US6242487B1 (en)	1996-12-03	2001-06-05	Lonza, Inc.	Carnitine supplemented diets for gestating and lactating swine

Also Published As

Publication number	Publication date
JPH0340010B2 (mo)	1991-06-17

Similar Documents

Publication	Publication Date	Title
KR920000324A (ko)	1992-01-29	필수 지방산 처리법
TNSN99163A1 (fr)	2005-11-10	COMPOSITION ANTIOXYDANTE COMPRENANT L'ACETYL-CARNITINE ET L'ACIDE α -LIPOIQUE QUI AMELIORE L'UTILISATION METABOLIQUE DU GLUCOSE
GB2276086A (en)	1994-09-21	Pharmaceutical products for curing tumorous diseases and process for preparing same
KR940018089A (ko)	1994-08-16	내부조직의 방사선 손상에 대한 예방 및 처치방법
IL103303A (en)	1997-06-10	Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
GB9517443D0 (en)	1995-10-25	Increasing creatine and glycogen concentration in muscle
CS545686A1 (en)	1988-07-15	Farmaceuticky prostredek a antihepatotoxickym pusobenim
SE8103003L (sv)	1981-11-16	Terapeutisk forfarande for behandling av diabetes och farmaceutisk komposition for genomforande av forfarandet
KR930000114A (ko)	1993-01-15	지방산을 이용한 치료
DE3751036D1 (de)	1995-03-16	Durch Carnitin dirigierte pharmazeutische Substanzen und ihre Verwendung zur Herstellung eines Arzneimittels zur Behandlung von Muskelerkrankungen.
JPS56104815A (en)	1981-08-20	Remedy for peripheral orthostatic hypotension
ES2136167T3 (es)	1999-11-16	Composiciones de idebenona para tratar la enfermedad de alzheimer.
JPS56152419A (en)	1981-11-26	Drug active to cardiad vessel, containing 1,2,5-oxydiazole-2-oxide substituted as pharmaceutical substance
CA2386770A1 (en)	2001-04-19	Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
ITRM920222A1 (it)	1993-09-27	Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine in associazione con ace-inibitori per il trattamento di patologie cardiovascolari.
CA2108330A1 (en)	1994-04-30	Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
KR920702225A (ko)	1992-09-03	약학 조성물
NZ303993A (en)	2000-12-22	Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
JPS57112331A (en)	1982-07-13	Medical composition of ganoderma lucidum component
CA2103707A1 (en)	1992-08-22	Treatment of non-small cell lung carcinoma
ZA837972B (en)	1984-11-28	Method of analgesic treatment and pharmaceutical compositions
KR900700102A (ko)	1990-08-11	심장질환 치료에 쓰이는 프로파페논과 퀴니딘의 지속성 조성물
DE68910010D1 (de)	1993-11-25	Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
DE3266072D1 (en)	1985-10-10	Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
IL101908A (en)	1997-09-30	Process for extraction of antineoplastic substances from plants of the family pittosporaceae, extracts obtained thereby, and pharmaceutical preparations containing them